Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related MNKD
MannKind, Sanofi Reach Agreement on AFREZZA; Sanofi to Purchase $10.2M Worth of Insulin from MannKind
Earnings Scheduled For November 9, 2016
MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference? (Seeking Alpha)
Related BRCD
10 Notable Stocks Trading Ex-Dividend Thursday, December 8
Keep an Eye on These 7 Stocks for November 21, 2016

MannKind (NASDAQ: MNKD) moved up 17.35% to $8.05 in the pre-market session after the company reported positive clinical data for AFREZZA.

Brocade Communications (NASDAQ: BRCD) soared 14.49% to $7.90 in the pre-market trading after the company reported better-than-expected fiscal third-quarter results.

Osiris Therapeutics (NASDAQ: OSIR) surged 9% to $27.73 in the pre-market session on clinical study results.

GenMark Diagnostics (NASDAQ: GNMK) shares gained 4.65% to $10.35 in the pre-market session after the company priced 7.6 million shares of common stock at $9.84.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (BRCD + GNMK)

View Comments and Join the Discussion!